 People on popular weight loss injectables like Ozempic and Zepbound may be able to switch from needles to pills soon. Pfizer says it's moving forward with a once-daily version of its drug, Denuglipron, after encouraging data in an ongoing early-stage study. This is CBS News. Sponsored by Progressive Insurance. Looking for a career path with flexibility, great pay, and benefits? Go to progressive.com slash careers and apply online today.